Disclosures for "Systemic Disease Impacts CNS Disease Control After SRS in Patients with Breast Cancer Brain Metastases"
-
Ms. Schick has nothing to disclose.
-
Dr. Hardy has received research support from the American Cancer Society.
-
Myla Strawderman has nothing to disclose.
-
Dr. Zheng has nothing to disclose.
-
The institution of Dr. Cummings has received research support from Siemans.
-
Michael Milano has received publishing royalties from a publication relating to health care.
-
Allison Magnuson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Clinical Oncology. The institution of Allison Magnuson has received research support from National Institute of Health. The institution of Allison Magnuson has received research support from Fair Health/Hartford Foundation.
-
Mrs. Behr has nothing to disclose.
-
Dr. Sammons has nothing to disclose.
-
Dr. Usuki has nothing to disclose.
-
The institution of Dr. Mohile has received research support from Novocure.
-
Dr. O'Regan has received personal compensation for serving as an employee of Pfizer. Dr. O'Regan has received personal compensation for serving as an employee of Biotheranostics. Dr. O'Regan has received personal compensation for serving as an employee of Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biotheranostics. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biotheranostics. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gilead. Dr. O'Regan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACS. Dr. O'Regan has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. O'Regan has received research support from Puma.
-
Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IPSEN. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seattle Genetics. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunomedics. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elucida. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athenex. Dr. Anders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Anders has received publishing royalties from a publication relating to health care. Dr. Anders has received publishing royalties from a publication relating to health care.
-
Dr. Hicks has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Hicks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica .
-
Dr. Hemminger has nothing to disclose.
-
Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Empire State Hematology Oncology. Dr. Dhakal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MJH Life Sciences. The institution of Dr. Dhakal has received research support from Puma Biotechnology. The institution of Dr. Dhakal has received research support from Celcuity.